Clinical trial
A Real-World Observational Study on Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation (Allo-SCT) and CAR-T Therapy
NCT07289087 is registered in ClinicalTrials.gov with Associazione Qol-one as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-World Observational Study on Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation (Allo-SCT) and CAR-T Therapy
- Lead sponsor
- Associazione Qol-one
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 15, 2026
- Completion date
- April 1, 2027
- Enrollment
- 162 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
allogeneic blood and marrow transplantation (bmt), car t cell therapy, patient reported outcome (pro), quality of life